In a recent prospective study involving 508 patients with Parkinson’s disease (PD), an investigation and analysis of cognitive impairment in PD patients revealed that a decrease in the UA to creatinine ratio was associated with increased accumulation of total-tau and phosphorylated-tau in cerebrospinal fluid. The gene discussed is MAPT; the disease is Cognitive impairment.